Torrent Pharmaceuticals Limited — Others, 27-12-2024: Trading Window

Torrent Pharmaceuticals has announced the closure of its trading window for designated persons effective from January 1, 2025, until 48 hours post the release of the financial results for the quarter and nine months ended December 31, 2024. This move aligns with the company's code of conduct to regulate trading activities.

The closure of the trading window signals a proactive measure to ensure compliance and maintain market integrity ahead of the financial disclosures. Investors should view this as a cautious stance, highlighting the company's commitment to transparency, though it may create short-term trading restrictions.